British Columbia Investment Management Corp Biolife Solutions Inc Transaction History

British Columbia Investment Management Corp

$16 Billion
Q3 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$17.67 - $26.07 $1.9 Million - $2.8 Million	107,551 Added 36.78%	400,000 $8.7 Million
Q1 2022 May 12, 2022	BUY	$20.81 - $37.29 $416,200 - $745,800	20,000 Added 7.34%	292,449 $6.65 Million
Q4 2021 Feb 11, 2022	BUY	$32.99 - $58.55 $1.81 Million - $3.22 Million	55,000 Added 25.29%	272,449 $10.2 Million
Q3 2021 Nov 12, 2021	SELL	$42.03 - $60.5 $1.3 Million - $1.88 Million	-31,000 Reduced 12.48%	217,449 $9.2 Million
Q2 2021 Aug 09, 2021	BUY	$29.51 - $44.62 $4.07 Million - $6.15 Million	137,913 Added 124.77%	248,449 $11.1 Million
Q1 2021 Apr 30, 2021	BUY	$32.95 - $44.24 $3.64 Million - $4.89 Million	110,536 New	110,536 $3.98 Million

Others Institutions Holding BLFS

# of Institutions

199

Shares Held

45M

Call Options Held

8.2K

Put Options Held

View Full List

About BIOLIFE SOLUTIONS INC

Ticker BLFS
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 42,684,400
Market Cap $1.11B
Description
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...

More about BLFS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of British Columbia Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on British Columbia Investment Management Corp with notifications on news.

Account